Finnish Institute for Health and Welfare: Hepatitis C in Finland is primarily transmitted through injection drug use
The Finnish Institute for Health and Welfare (THL) has released new information regarding the situation of hepatitis C infections in Finland. According to the agency, the majority of hepatitis C cases in the country are linked to injection drug use. This finding highlights the public health challenges associated with substance use and the prevention of infectious diseases.
According to the report, hepatitis C is a serious liver disease that spreads through the blood. In Finland, infections are concentrated particularly among population groups that use intravenous drugs. According to THL, the availability of clean injection equipment and health counseling are key methods for reducing the number of infections in the future.
Experts remind that hepatitis C is often a long-term illness that can cause serious damage to the liver if not treated in time. Although the disease is serious, modern medical treatments are highly effective. The goal in Finland is to improve access to testing and treatment for those infected so that the spread of the virus can be brought under control.
THL continues to monitor the situation and collaborate with wellbeing services counties. The goal is to strengthen low-threshold services so that help is more easily accessible to those at the highest risk of infection. Increasing awareness and preventive work will continue to play a central role in the Finnish healthcare system.